Skip to main content
Veterinary Medicines

Advantage 40 Spot-on solution for Cats

Authorised
  • Imidacloprid

Product identification

Medicine name:
Frento Forte Flohschutztropfen 40 mg Lösung zum Auftropfen für kleine Katzen
Advantage 40 Spot-on solution for Cats
Active substance:
  • Imidacloprid
Target species:
  • Cat
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Imidacloprid
    40.00
    milligram(s)
    /
    0.40
    millilitre(s)
Pharmaceutical form:
  • Spot-on solution
Withdrawal period by route of administration:
  • Cutaneous use
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AX17
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • Pack sizes 0.4 ml solution per pipette, Pack containing 6 unit dose pipettes, Container: White polypropylene pipettes with caps
  • Pack sizes 0.4 ml solution per pipette, Pack containing 4 unit dose pipettes, Container: White polypropylene pipettes with caps
  • Pack sizes 0.4 ml solution per pipette, Pack containing 3 unit dose pipettes, Container: White polypropylene pipettes with caps
  • Pack sizes 0.4 ml solution per pipette, Pack containing 2 unit dose pipettes, Container: White polypropylene pipettes with caps
  • Pack sizes 0.4 ml solution per pipette, Pack containing 1 unit dose pipettes, Container: White polypropylene pipettes with caps

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • KVP Pharma+Veterinär Produkte GmbH
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA22020/045/001
Date of authorisation status change:
Reference member state:
  • Austria
Procedure number:
  • AT/V/0021/001
Concerned member states:
  • Denmark
  • Germany
  • Ireland
  • Italy
  • Netherlands
  • Norway
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."